Manipulation of Mouse Hematopoietic Progenitors by Specific Retroviral Infection

This publication has 32 references indexed in Scilit:

• In Vivo Treatment of Hemophilia A and Mucopolysaccharidosis Type VII Using Nonprimate Lentiviral Vectors
  Molecular Therapy, 2001
• Receptor-Specific Targeting Mediated by the Coexpression of a Targeted Murine Leukemia Virus Envelope Protein and a Binding-Defective Influenza Hemagglutinin Protein
  Human Gene Therapy, 2001
• Hematopoietic stem cell gene therapy: towards clinically significant gene transfer efficiency
  Immunological Reviews, 2000
• TARGETING ACTIVATED LYMPHOCYTES WITH AN ENTIRELY HUMAN IMMUNOTOXIN ANALOGUE: HUMAN PANCREATIC RNASE1-HUMAN IL-2 FUSION
  Cytokine, 2000
• Retroviral Vector Targeting Human Cells via c-Kit–Stem Cell Factor Interaction
  Human Gene Therapy, 1998
• Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6
  Bone Marrow Transplantation, 1998
• Tissue-Specific Targeting of Retroviral Vectors Through Ligand-Receptor Interactions
  Science, 1994
• A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor
  Cell, 1993
• Chicken “erythroid” cells transformed by the Gag-Myb-Ets-encoding E26 leukemia virus are multipotent
  Cell, 1992
• Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell?
  Nature, 1979